查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1509626

2024 年藥物釋放型支架全球市場報告

Drug Eluting Stent Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

藥物釋放型支架的市場規模預計在未來幾年將強勁成長。 2028年將以8.4%的年複合成長率（CAGR）成長至105.2億美元。預測期內的預期成長是由於人口老化和慢性病負擔、適應症擴大、醫療報銷政策、不斷擴大的全球市場以及強調以患者為中心的護理等因素造成的。預測期內預計的主要趨勢包括個人化醫療、微創技術、新興醫療技術、下一代配方等。

心臟疾病負擔的增加預計將推動藥物釋放型支架市場的未來擴張。當冠狀動脈因斑塊堆積而變窄或阻塞時，就會發生冠狀動脈疾病（CHD），這可能會導致心臟病和胸痛等嚴重併發症。久坐的生活方式、不良的飲食習慣、人口老化和意識的提高正在導致心臟疾病的盛行率不斷上升。藥物釋放型支架（DES）透過有效地擴張狹窄或閉塞的冠狀動脈並釋放藥物以防止動脈血管再阻塞血管再阻塞（Masu），在心臟疾病的治療中發揮重要作用。例如，根據美國疾病管制與預防中心的數據，18 歲及以上成年人的心臟疾病率將從 2020 年的 4.6% 增加到 2022 年的 4.9%。心臟疾病負擔日益增加的趨勢預計將推動藥物釋放型支架市場的成長。

藥物釋放型支架市場上的公司專注於開發創新的輸送系統，例如雙層球囊，以改善患者的治療效果並推動介入性心臟病學。藥物釋放型支架系統中的雙層球囊透過允許藥物均勻地塗布和控制到動脈壁來提高藥物輸送和支架放置的精確度。例如，2022年8月，美敦力公司推出了Onyx，這是一種最新一代藥物釋放型冠狀動脈支架系統，旨在增強輸送系統，基於上一代Resolute Onyx DES的急性性能和臨床資料，我們宣布了Frontier 。 Onyx Frontier DES 採用與 Resolute Onyx 相同的高品質支架平台，具有廣泛的尺寸範圍，可治療直徑從 2.0 毫米到 5.0 毫米的患者。顯著的設計改進，包括創新的兩層球囊、減少的橫截面和增加的導管靈活性，與上一代 Resolute Onyx DES 相比，增加了輸送能力，同時保持徑向強度提高了 16%。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球藥物釋放型支架市場：促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球藥物釋放型支架市場表現：規模與成長，2018-2023
  • 全球藥物釋放型支架市場預測：規模與成長，2023-2028，2033F

第6章 市場細分

  • 全球藥物釋放型支架市場：按產品分類的績效與預測，2018-2023、2023-2028F、2033F
  • 聚合物基
  • 不含聚合物
  • 全球藥物釋放型支架市場：依藥物分類的表現與預測，2018-2023、2023-2028F、2033F
  • Sirolimus
  • 紫杉醇
  • 佐他莫司
  • Everolimus
  • 比奧莫司
  • 其他藥品
  • 全球藥物釋放型支架市場：支架性能與預測，2018-2023、2023-2028F、2033F
  • 鈷鉻合金
  • 鉑鉻
  • 鎳鈦諾
  • 生物分解性
  • 其他支架
  • 全球藥物釋放型支架市場：按應用分類的表現和預測，2018-2023、2023-2028F、2033F
  • 冠狀動脈疾病
  • 周邊血管疾病
  • 全球藥物釋放型支架市場：最終用戶的表現與預測，2018-2023、2023-2028F、2033F
  • 醫院
  • 專科診所

第 7 章 區域/國家分析

  • 全球藥物釋放型支架市場：按地區分類的績效與預測，2018-2023、2023-2028F、2033F
  • 全球藥物釋放型支架市場：按國家/地區分類的績效和預測，2018-2023、2023-2028F、2033F

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 藥物釋放型支架市場：競爭格局
  • 藥物釋放型支架市場：公司簡介
    • Johnson & Johnson Services Inc.
    • Abbott
    • Medtronic plc
    • Boston Scientific Corporation
    • Terumo Corporation

第31章 其他大型創新企業

  • InspireMD Inc.
  • B. Braun Melsungen AG
  • Cook Group Incorporated
  • Lepu Medical Technology（Beijing）Co. Ltd.
  • Biotronik
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Biosensors International Group Ltd.
  • OrbusNeich Medical Company Limited
  • Alvimedica Medical Technologies
  • Hexacath
  • Elixir Medical Corporation
  • Translumina GmbH
  • Cardionovum GmbH
  • QualiMed Innovative Medizinprodukte GmbH

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章前瞻性與潛力分析

第36章附錄

簡介目錄
Product Code: r18123

A drug-eluting stent (DES) is a medical device employed in the treatment of coronary artery disease (CAD). It constitutes a small, mesh-like tube typically constructed from metal, which is inserted into narrowed or blocked coronary arteries during a procedure known as percutaneous coronary intervention (PCI) or angioplasty.

The primary product types of drug-eluting stents include polymer-based and polymer-free varieties. Polymer-based drug-eluting stents (DES) are stents coated with a thin polymer layer that encapsulates the drug(s) intended for delivery to the arterial wall. These drugs may include sirolimus, paclitaxel, zotarolimus, everolimus, biolimus, among others, with scaffolds such as cobalt-chromium, platinum-chromium, nitinol, biodegradable materials, and others. They find application in coronary diseases and peripheral vascular disease and are utilized by end-users such as hospitals and specialty clinics.

The drug eluting stent market research report is one of a series of new reports from The Business Research Company that provides drug eluting stent market statistics, including drug eluting stent industry global market size, regional shares, competitors with a drug eluting stent market share, detailed drug eluting stent market segments, market trends and opportunities, and any further data you may need to thrive in the drug eluting stent industry. This drug eluting stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug eluting stent market size has grown strongly in recent years. It will grow from $7.05 billion in 2023 to $7.63 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The historical growth can be attributed to the necessity for enhanced treatment options, clinical evidence, regulatory approvals, healthcare economics, and guidelines and recommendations.

The drug eluting stent market size is expected to see strong growth in the next few years. It will grow to $10.52 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The anticipated growth in the forecast period can be attributed to factors such as an aging population and the burden of chronic diseases, expanded indications, healthcare reimbursement policies, global market expansion, and the emphasis on patient-centered care. Significant trends expected in the forecast period encompass personalized medicine, minimally invasive techniques, emerging healthcare technologies, and next-generation drug formulations.

The increasing burden of coronary heart disease is projected to drive the expansion of the drug-eluting stent market in the future. Coronary heart disease (CHD) occurs when the coronary arteries become narrowed or blocked due to plaque accumulation, potentially leading to severe complications such as heart attacks or chest pain. Sedentary lifestyles, poor dietary habits, aging populations, and heightened awareness contribute to the rising prevalence of coronary heart disease. Drug-eluting stents (DES) play a crucial role in managing coronary heart disease by effectively widening narrowed or blocked coronary arteries and releasing medication to prevent re-narrowing (restenosis) of the artery. For example, according to the Centers for Disease Control and Prevention, the percentage of adults aged 18 and over with coronary heart disease increased from 4.6% in 2020 to 4.9% in 2022. This upward trend in coronary heart disease burden is expected to fuel the growth of the drug-eluting stent market.

Companies operating in the drug-eluting stent market are directing their efforts toward developing innovative delivery systems, such as the dual-layer balloon, to enhance patient outcomes and advance interventional cardiology. A dual-layer balloon within a drug-eluting stent system improves precision in drug delivery and stent deployment by offering better control and uniform drug application to the arterial wall. For instance, in August 2022, Medtronic Plc introduced Onyx Frontier, the latest generation of drug-eluting coronary stent systems designed to enhance delivery systems, building upon the acute performance and clinical data from the previous Resolute Onyx DES generation. The Onyx Frontier DES utilizes the same high-quality stent platform as Resolute Onyx and features a wide size range to treat patients with diameters ranging from 2.0mm to 5.0mm. Notable design enhancements include a groundbreaking dual-layer balloon, reduced crossing profile, and enhanced catheter flexibility, resulting in a 16% increase in deliverability compared to the previous Resolute Onyx DES generation, while maintaining radial strength.

In October 2023, Cordis acquired MedAlliance for an undisclosed sum. This acquisition is aimed at furthering Cordis' tradition of cardiovascular innovation and expanding its product portfolio in the coronary and peripheral vascular markets. MedAlliance is a Switzerland-based medical device manufacturer and distributor specializing in drug-eluting stents.

Major companies operating in the drug eluting stent market are Johnson & Johnson Services Inc., Abbott, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, InspireMD Inc., B. Braun Melsungen AG, Cook Group Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Biotronik, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, Biosensors International Group Ltd., OrbusNeich Medical Company Limited, Alvimedica Medical Technologies, Hexacath, Elixir Medical Corporation, Translumina GmbH, Cardionovum GmbH, QualiMed Innovative Medizinprodukte GmbH, InSitu Technologies Inc., Acrostak AG, SINOMED Innovation Inc., Svelte Medical Systems Inc.

North America was the largest region in the drug-eluting stent market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug eluting stent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug eluting stent market consists of revenues earned by entities by providing services such as pre-procedural assessment, procedural intervention, intraoperative monitoring, post-procedural care, and patient education. The market value includes the value of related goods sold by the service provider or included within the service offering. The drug eluting stenting market also includes sales of products including guide wires, angioplasty equipment, intravascular imaging systems, hemostasis devices, and diagnostic tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Eluting Stent Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug eluting stent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug eluting stent? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug eluting stent market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Polymer-Based; Polymer-Free
  • 2) By Drug: Sirolimus; Paclitaxel; Zotarolimus; Everolimus; Biolimus; Other Drugs
  • 3) By Scaffold: Cobalt-Chromium; Platinum-Chromium; Nitinol; Biodegradable; Other Scaffolds
  • 4) By Application: Coronary Diseases; Peripheral Vascular Diseases
  • 5) By End-User: Hospitals; Specialty Clinics
  • Companies Mentioned: Johnson & Johnson Services Inc.; Abbott; Medtronic plc; Boston Scientific Corporation; Terumo Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Eluting Stent Market Characteristics

3. Drug Eluting Stent Market Trends And Strategies

4. Drug Eluting Stent Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Drug Eluting Stent Market Size and Growth

  • 5.1. Global Drug Eluting Stent Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Drug Eluting Stent Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Drug Eluting Stent Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drug Eluting Stent Market Segmentation

  • 6.1. Global Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Polymer-Based
  • Polymer-Free
  • 6.2. Global Drug Eluting Stent Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Sirolimus
  • Paclitaxel
  • Zotarolimus
  • Everolimus
  • Biolimus
  • Other Drugs
  • 6.3. Global Drug Eluting Stent Market, Segmentation By Scaffold, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cobalt-Chromium
  • Platinum-Chromium
  • Nitinol
  • Biodegradable
  • Other Scaffold
  • 6.4. Global Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Coronary Diseases
  • Peripheral Vascular Diseases
  • 6.5. Global Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics

7. Drug Eluting Stent Market Regional And Country Analysis

  • 7.1. Global Drug Eluting Stent Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Drug Eluting Stent Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drug Eluting Stent Market

  • 8.1. Asia-Pacific Drug Eluting Stent Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drug Eluting Stent Market

  • 9.1. China Drug Eluting Stent Market Overview
  • 9.2. China Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drug Eluting Stent Market

  • 10.1. India Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drug Eluting Stent Market

  • 11.1. Japan Drug Eluting Stent Market Overview
  • 11.2. Japan Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drug Eluting Stent Market

  • 12.1. Australia Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drug Eluting Stent Market

  • 13.1. Indonesia Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drug Eluting Stent Market

  • 14.1. South Korea Drug Eluting Stent Market Overview
  • 14.2. South Korea Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drug Eluting Stent Market

  • 15.1. Western Europe Drug Eluting Stent Market Overview
  • 15.2. Western Europe Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drug Eluting Stent Market

  • 16.1. UK Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drug Eluting Stent Market

  • 17.1. Germany Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drug Eluting Stent Market

  • 18.1. France Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drug Eluting Stent Market

  • 19.1. Italy Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drug Eluting Stent Market

  • 20.1. Spain Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drug Eluting Stent Market

  • 21.1. Eastern Europe Drug Eluting Stent Market Overview
  • 21.2. Eastern Europe Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drug Eluting Stent Market

  • 22.1. Russia Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drug Eluting Stent Market

  • 23.1. North America Drug Eluting Stent Market Overview
  • 23.2. North America Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drug Eluting Stent Market

  • 24.1. USA Drug Eluting Stent Market Overview
  • 24.2. USA Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drug Eluting Stent Market

  • 25.1. Canada Drug Eluting Stent Market Overview
  • 25.2. Canada Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drug Eluting Stent Market

  • 26.1. South America Drug Eluting Stent Market Overview
  • 26.2. South America Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drug Eluting Stent Market

  • 27.1. Brazil Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drug Eluting Stent Market

  • 28.1. Middle East Drug Eluting Stent Market Overview
  • 28.2. Middle East Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drug Eluting Stent Market

  • 29.1. Africa Drug Eluting Stent Market Overview
  • 29.2. Africa Drug Eluting Stent Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Drug Eluting Stent Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Drug Eluting Stent Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drug Eluting Stent Market Competitive Landscape And Company Profiles

  • 30.1. Drug Eluting Stent Market Competitive Landscape
  • 30.2. Drug Eluting Stent Market Company Profiles
    • 30.2.1. Johnson & Johnson Services Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Medtronic plc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Boston Scientific Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Terumo Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Drug Eluting Stent Market Other Major And Innovative Companies

  • 31.1. InspireMD Inc.
  • 31.2. B. Braun Melsungen AG
  • 31.3. Cook Group Incorporated
  • 31.4. Lepu Medical Technology (Beijing) Co. Ltd.
  • 31.5. Biotronik
  • 31.6. Meril Life Sciences Pvt. Ltd.
  • 31.7. MicroPort Scientific Corporation
  • 31.8. Biosensors International Group Ltd.
  • 31.9. OrbusNeich Medical Company Limited
  • 31.10. Alvimedica Medical Technologies
  • 31.11. Hexacath
  • 31.12. Elixir Medical Corporation
  • 31.13. Translumina GmbH
  • 31.14. Cardionovum GmbH
  • 31.15. QualiMed Innovative Medizinprodukte GmbH

32. Global Drug Eluting Stent Market Competitive Benchmarking

33. Global Drug Eluting Stent Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Drug Eluting Stent Market

35. Drug Eluting Stent Market Future Outlook and Potential Analysis

  • 35.1 Drug Eluting Stent Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Drug Eluting Stent Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Drug Eluting Stent Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer